Navigation Links
Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System
Date:6/17/2009

FRANKLIN, Mass., June 17 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE) announced today that it has signed a license agreement with Handok Pharmaceuticals Co., Ltd. ("Handok"), the largest diabetes care-focused pharmaceutical company in South Korea, under which Echo granted Handok rights to develop, market, sell and distribute Echo's Symphony(TM) tCGM System ("Symphony") for painless, needle-free, transdermal, continuous glucose monitoring ("tCGM") in medical facilities and by diabetics in South Korea. Echo's non-invasive Symphony tCGM System incorporates its Prelude(TM) SkinPrep System, a patented skin ablation control technology which allows for quick and painless removal of the outermost layer of the skin for transdermal drug delivery and glucose management. The Symphony tCGM System is designed to provide both diabetics and medical professionals with a reliable, needle-free, easy-to-use, affordable and comfortable-to-wear continuous glucose monitoring device.

"This initial commercial partnering arrangement for our Symphony tCGM System is a strategically significant component of our plan to develop and market this important next-generation technology worldwide. Closing this second licensing transaction this quarter was one of our top priorities," stated Patrick T. Mooney, M.D., Chairman and Chief Executive Officer of Echo Therapeutics. "Handok is the market leader in diabetes care in South Korea with a long history of ethical patient care. This new collaboration combines our deep expertise in transdermal continuous glucose monitoring and Handok's leadership in the large and rapidly expanding glucose monitoring market in South Korea."

Young Jin Kim, Chairman and Chief Executive Officer of Handok added, "We are extremely excited about our relationship with Echo. We believe that our ability to market and sell Symphony will expand our leadership position in the hospital and diabetes care marke
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
2. Elusys Therapeutics and Lonza Enter Into Manufacturing Agreement
3. Prospect Therapeutics In Vitro Studies Demonstrate that GCS-100 Drug Binds to and Blocks the Effects of Galectin-3
4. Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Issuance and Sale of Stock
5. Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R)
6. InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeting
7. Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281
8. Oxygen Biotherapeutics, Inc. Announces Private Placement Financing Agreement and Offer to Acquire Warrants
9. Ludwig Institute of Cancer Research Ltd., Brussels Branch, Issues Statement Concerning Prospect Therapeutics Incs. GCS-100 Molecule
10. Natura Therapeutics and USF receive NIH grant to study green tea compound for Alzheimers
11. Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... in the coronary arteries of chronic kidney disease patients ... according to a new study in the Journal ... ). Researchers at the Johns Hopkins Bloomberg School of ... commonly used measures of subclinical atherosclerosis in predicting the ... , Approximately 50 percent of all patients with chronic ...
(Date:8/21/2014)... 21, 2014 Pulmonary Hypertension Association ... Education Forum for PH patients and families to ... Pulmonary Hypertension Association – the country’s leading ... to prevent and cure pulmonary hypertension (PH) – ... functioning of the heart and can lead right ...
(Date:8/21/2014)... environmental source of fungal infections that have been sickening ... grows on trees. , The discovery is based on ... the summer gathering soil and tree samples from areas ... fungus named Cryptococcus gattii (CRIP-to-cock-us GAT-ee-eye). ... of species including C. gattii , causes life-threatening ...
(Date:8/21/2014)... 2014 (HealthDay News) -- Black mothers are less likely ... one possible reason why: Hospitals in neighborhoods with many ... in areas with more white residents, a U.S. government ... much less common in medical centers where the black ... Centers for Disease Control and Prevention reported Thursday. ...
(Date:8/21/2014)... (HealthDay News) -- Among seniors, dimming vision may be ... involved more than 2,500 people, aged 65 to 84, who ... two, six and eight years later. Vision loss over ... of death during the study period, the researchers reported. ... by Sharon Christ of Purdue University in West Lafayette, Ind., ...
Breaking Medicine News(10 mins):Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 3Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2
... activities and helping others is not just good for the ... other addicts become and stay sober, a researcher from Case ... review article published in the Volume 29 issue of ... of psychiatry at the School of Medicine, sheds light on ...
... , FRIDAY, Jan. 28 (HealthDay News) -- A new ... work better in people with high levels of a certain protein ... Researchers found that the drugs work the same -- at ... diabetics -- regardless of the results of a test that looks ...
... Salamon HealthDay Reporter , THURSDAY, Jan. 27 (HealthDay ... opening in his small Louisiana town, where vacant storefronts have ... an assistant professor of sociology at Southeastern Louisiana University, wasn,t ... flat-screened TVs -- one in every booth -- along with ...
... Celiac disease and Crohn,s disease share several genetic risk factors, ... hard to absorb nutrients properly, is an inherited autoimmune disease ... by gluten and other protein found in wheat and some ... disease. An international team of researchers conducted a meta-analysis ...
... type of breast cancer in older women estrogen and ... to a protein that fends off aging-related cellular damage. ... Gius, M.D., Ph.D., now shows how a deficiency in this ... develop. The findings, published in Molecular Cell , ...
... THURSDAY, Jan. 27 (HealthDay News) -- Arizona Congresswoman Gabrielle ... stunning step forward for the lawmaker who was shot ... at TIRR Memorial Hermann Hospital could last several months. ... planned to insert a valve into her breathing tube, ...
Cached Medicine News:Health News:Helping others helps alcoholics stay on the road to recovery, Case Western Reserve shows 2Health News:Helping others helps alcoholics stay on the road to recovery, Case Western Reserve shows 3Health News:Blood Protein Level May Not Influence Effectiveness of Statins 2Health News:TV: A Sneaky Part of the Food Pyramid 2Health News:TV: A Sneaky Part of the Food Pyramid 3Health News:Protein related to aging holds breast cancer clues 2Health News:Rep. Giffords' Intensive Rehab Under Way 2Health News:Rep. Giffords' Intensive Rehab Under Way 3
(Date:8/21/2014)... FAIRFAX, Va. , Aug. 21, 2014 /PRNewswire/ ... real-time quality and Manufacturing Intelligence , today ... Intelligence Conference. The event will be held Oct. ... Mile, and is designed to showcase the necessity ... use of metrics and Manufacturing Intelligence to gain ...
(Date:8/21/2014)... 21, 2014  AliveCor, Inc. announced today ... (FDA) has granted the company clearance for ... the most common form of cardiac arrhythmia. ... if patients are experiencing AFib through real-time ... phone based AliveCor® Heart Monitor, so physicians ...
(Date:8/21/2014)...  The board of directors of VirtualScopics, Inc. (NASDAQ: ... trial imaging solutions, today announced that James Groff ... immediately.  Mr. Groff has held the role of acting ... in January 2006 as an accounting manager and was ... the board of VirtualScopics asked Jim to assume the ...
Breaking Medicine Technology:InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4
... Pharmaceuticals, Inc. (Nasdaq: TRBN ) today announced financial ... Sept. 30, 2009. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090320/TRUBIONLOGO ) , ... , Revenue for the third quarter and ... and $12.8 million, respectively, compared with $3.8 million and ...
... SADDLE RIVER, N.J., Nov. 5 PDI, Inc. (Nasdaq: PDII), ... to U.S. pharmaceutical companies, today reported financial and operational results ... Commenting on today,s announcement, Nancy Lurker, Chief Executive Officer of ... were lower than last year by approximately 14%. Higher ...
Cached Medicine Technology:Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 2Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 3Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 4Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 5Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 6Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results 7PDI Reports 2009 Third Quarter Financial Results 2PDI Reports 2009 Third Quarter Financial Results 3PDI Reports 2009 Third Quarter Financial Results 4PDI Reports 2009 Third Quarter Financial Results 5PDI Reports 2009 Third Quarter Financial Results 6PDI Reports 2009 Third Quarter Financial Results 7PDI Reports 2009 Third Quarter Financial Results 8PDI Reports 2009 Third Quarter Financial Results 9PDI Reports 2009 Third Quarter Financial Results 10PDI Reports 2009 Third Quarter Financial Results 11
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 7.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 9 mm....
Medicine Products: